61/100Is IBM-International Business Machines a buy?
Tuesday 14 July 2026
Why now: IBM is being repriced in real time after management released selected preliminary 2Q 2026 results that came in below expectations, creating a rare “reset” moment for a mega-cap, dividend-paying enterprise name. The timing edge is not momentum; it is the chance to re-underwrite the long-term cash-flow story at a materially lower print before the full 2Q release and call on July 22, 2026.
Upside: If IBM can show on the July 22, 2026 earnings call that the Q2 miss was mainly timing and capex mix (not a lasting demand problem), a partial valuation re-rating back toward the pre-gap area could create meaningful upside from the current premarket print. A reasonable 12-month upside case is a recovery toward the mid-$260s to high-$280s if execution stabilizes and guidance holds, but this depends on confidence rebuilding, not just one quarter of numbers.
Risks: The near-term risk is that the preliminary disclosure is the first step in a broader guide-down cycle, especially if mainframe-related performance and attached software remain weaker than expected. The second key risk is that enterprise budgets continue shifting toward non-IBM AI infrastructure purchases, keeping IBM’s growth more muted than the market previously priced in.
Scorecard
| Scorecard | 61/100 | |
|---|---|---|
| Company Detail | IBM - International Business Machines Corporation | |
| Price as at 13 July 2026 | $290.23 | |
| Market cap | $272.8B | |
| Quality and Fundamental Score (100) | ||
| Breakout / Early-Momentum /20 | 5/20 | |
| Rev/EPS Momentum /20 | 11/20 | |
| Business Quality /15 | 12/15 | |
| Balance Sheet /15 | 10/15 | |
| Valuation /10 | 7/10 | |
| Industry Relative Strength /10 | 6/10 | |
| Macro / Sector Tailwind /10 | 10/10 | |
| Growth (mechanical) | ||
| Cash runway | Cash generative | |
| Revenue YoY | +7.6% | |
| EPS YoY | +73.7% | |
| FCF YoY | -2.6% | |
| Gross margin | 58.2% | |
| Valuation & Trend | ||
| Trailing P/E | 25.7x | |
| Forward P/E | 21.5x | |
| RSI (14d) | 57 | |
| vs 50d SMA | +10.4% | |
| Support cushion | −6.1% | |
| Sentiment | ||
| Wall Street verdict | Aligned | |
| News tone | Mixed | |
| Dividend | 2.4% | |
How are these colored?
| Metric | Strong metrics | Solid metrics | Selective | Caution | Unfavourable |
|---|---|---|---|---|---|
| Overall score | ≥ 80 | 70-79 | 60-69 | 50-59 | < 50 |
| Business quality /15 | ≥ 12 | 10-11 | 8-9 | 6-7 | < 6 |
| Balance sheet /15 | ≥ 12 | 10-11 | 8-9 | 6-7 | < 6 |
| Market cap | ≥ $20B | $5B-$20B | $2B-$5B | $1B-$2B | < $1B |
| Cash runway | ≥ 3 yr or cash generative | 1.5-3 yr | 0.75-1.5 yr | 0.25-0.75 yr | < 0.25 yr |
| Revenue YoY | ≥ 15% | 5-15% | 0-5% | -5-0% | < -5% |
| EPS YoY | ≥ 20% | 5-20% | 0-5% | -5-0% | < -5% |
| FCF YoY | ≥ 10% | 1-10% | 0-1% | -5-0% | < -5% |
| Gross margin | ≥ 60% | 40-60% | 25-40% | 10-25% | < 10% |
| Trailing P/E | < 15 | 15-25 | 25-35 | 35-40 | > 40 or neg |
| Forward P/E | < 15 | 15-25 | 25-35 | 35-40 | > 40 or neg |
| RSI (14d) | 50-70 | 45-50 or 70-75 | 40-45 or 75-78 | 30-40 or 78-80 | < 30 or > 80 |
| vs 50d SMA | +2% to +15% | 0-2% or 15-25% | -2-0% or 25-35% | -3--2% or 35-40% | < -3% or > 40% |
| Support cushion | 2-10% above | 0-2% | 10-15% | 15-20% | price below support |
| Wall Street verdict | Aligned | — | Mixed | — | Disagrees |
| News tone | Positive | — | Neutral / Mixed | — | Negative |
| Dividend | Yield ≥ 2% & growing | Growing | Flat payer ≥ 1% | Low / flat | Cutting |
Detailed Analysis — Tuesday 14 July 2026
Arvind Krishna has been Chief Executive Officer since April 2020.
James J.
Receiver of capital expenditure: Yes — IBM is a receiver of customer capex because large clients fund multi-year modernization, infrastructure refreshes, and hybrid cloud buildouts, but those budgets can shift quarter-to-quarter toward other infrastructure priorities.
Main customers
- Financial services (banks and insurers) (Large regulated enterprises buying hybrid cloud platforms, security, data and automation software, and consulting for modernization and risk controls.)
- Government and public sector (Agencies buying secure infrastructure, modernization services, and IT systems where compliance and resiliency matter.)
Notable contracts
- Defense Commissary Agency contract (electronic shelf label modernization) (IBM announced it was awarded a contract to modernize the agency’s electronic shelf label system; scope and economics were not specified in the announcement reviewed.)
- IBM remains a high-importance enterprise vendor in hybrid cloud and regulated-industry IT, and it has historically supported investors with steady cash generation and a meaningful dividend.
- The long-term question is whether IBM can deliver consistent, software-led growth while infrastructure cycles and customer capex priorities swing.
- Today’s premarket gap forces a clean re-check: if the Q2 weakness is mostly product-cycle timing plus capex mix, the stock can rebuild; if it is a sign that IBM’s legacy-linked profit engine is more fragile than believed, the reset can take longer than investors expect.
Show 5 headlines from the last 7d
Scores 61 out of 100 — a mixed overall grade. Sector fit and business quality scored highest. Valuation and balance sheet were fair but not standout drivers. Chart setup weighed on the total. Score capped by today’s preliminary 2Q 2026 shortfall versus expectations and the related credibility hit, plus the fact the current chart snapshot is not in a confirmed breakout state and today’s tape is a large downside gap that can take time to repair.
Component scores are on the scorecard above.
- On the last completed daily bar, IBM was above its 50-day and 200-day moving averages, but it was not in a confirmed breakout setup and its industry relative strength score was slightly below 50, meaning it was not leading the broader technology neighborhood.
- The current tape is dominated by a roughly 20% premarket gap down versus the prior close, which overrides the prior technical picture and implies the next few sessions will be about repairing trust and finding a new base, not trend-following.
- On July 14, 2026, IBM released selected preliminary 2Q 2026 results showing revenue of $17.2 billion (up 1%), software revenue up 5%, consulting roughly flat (up 1% at constant currency), and infrastructure down 7%, along with operating (non-GAAP) EPS of $2.93.
- Management attributed the shortfall to weaker-than-expected IBM Z performance and the associated software stack, plus late-quarter customer capex shifting toward servers, storage, and memory purchases ahead of expected price increases, and added that clients were also distracted by rapidly evolving, industry-wide cybersecurity concerns.
- From the latest finalized quarter available in filings and the company’s prior update, IBM reported first-quarter 2026 free cash flow of about $2.2 billion and maintained an outlook for more than 5% constant-currency revenue growth for 2026 with free cash flow expected to increase by about $1 billion year over year.
- Balance sheet leverage remains a real constraint for a “steady compounder” narrative: at March 31, 2026, total debt (including IBM Financing debt) was disclosed around the mid-$60 billions and had increased versus year-end 2025, which makes stability and cash conversion more important than headline growth.
Cash runway: Cash generative (latest annual free cash flow is positive).
Upcoming (1–6 months)
- IBM second-quarter 2026 earnings release and conference call on July 22, 2026, including whether full-year 2026 constant-currency growth and free cash flow expectations are reaffirmed or reduced.
Ongoing
- Infrastructure and transaction-processing related performance in coming quarters, including whether the Q2 shortfall reverses or persists and how software growth behaves when mainframe cycle strength fades.
Risks
- A multi-quarter enterprise spending shift away from IBM’s higher-margin attached software and toward non-IBM AI infrastructure and alternative platforms, keeping growth and margins below what the market previously expected.
Breaks the thesis
- Failure to stabilize after today’s gap with continued heavy selling and acceptance below the $229 to $230 area, followed by a full-year outlook reduction on or before the July 22, 2026 earnings call.
